dr sonneveld on the fda approval of subcutaneous daratumumab plus vrd in myeloma
Published 3 months ago • 47 plays • Length 2:24Download video MP4
Download video MP3
Similar videos
-
1:07
fda approval of frontline daratumumab plus vmp in multiple myeloma
-
2:05
dr sonneveld on the background of the d-vrd regimen in newly diagnosed myeloma
-
0:38
dr. berdeja on fda approval of frontline daratumumab plus vmp in multiple myeloma
-
0:59
dr. fonseca on fda approval of daratumumab triplets in multiple myeloma
-
15:09
subcutaneous daratumumab — dr. jonathan kaufman | mcrt webcast july 11
-
1:48
dr. usmani on subcutaneous delivery of daratumumab in myeloma
-
6:55
pereus update d-vrd vs vrd newly diagnosed transplant eligible | pieter sonneveld, md | eha 2024
-
1:05
dr. harrison on subcutaneous daratumumab and isatuximab in myeloma
-
3:07
what does the fda approval of sarclisa® (isatuximab) mean for myeloma patients?
-
2:24
daratumumab plus vrd for multiple myeloma | nejm
-
0:52
dr. wong discusses the fda approval of elotuzumab triplet in myeloma
-
1:17
dr. bahlis on daratumumab plus lenalidomide and dexamethasone in multiple myeloma
-
1:57
dr. shah on daratumumab-based regimens in frontline multiple myeloma
-
1:34
dr. anderson on recent fda approvals in multiple myeloma
-
0:58
#knowmyeloma fda approved 4-drug combination for newly diagnosed multiple myeloma
-
11:24
daratumumab in multiple myeloma
-
4:08
what is the latest on a new drug called selinexor?
-
1:02
dr. shain on subcutaneous therapy for patients with multiple myeloma
-
3:05
sc daratumumab plus standard-of-care regimens in myeloma